
This study evaluated #triptorelin treatment for #prostatecancer (2010-2021) in 3,411 Italian patients (mean age 76.8). Patients received triptorelin alone (38.9%) or with anti-androgens (61.1%); 24.8% died, 30.4% switched treatments. |journals.aboutscience.eu/index.php/grht…

English


















